10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $538,725 | -23.8% | 13,060 | +3.2% | 0.01% | -22.2% |
| Q2 2023 | $706,934 | +8.6% | 12,660 | +8.5% | 0.01% | -10.0% |
| Q1 2023 | $651,125 | +59.3% | 11,671 | +4.0% | 0.01% | +42.9% |
| Q4 2022 | $408,747 | +42.4% | 11,217 | +11.3% | 0.01% | +16.7% |
| Q3 2022 | $287,000 | -33.4% | 10,079 | +5.9% | 0.01% | -33.3% |
| Q2 2022 | $431,000 | -40.6% | 9,521 | -0.2% | 0.01% | -25.0% |
| Q1 2022 | $726,000 | -49.2% | 9,541 | -0.6% | 0.01% | -45.5% |
| Q4 2021 | $1,430,000 | +4.8% | 9,602 | +2.4% | 0.02% | -15.4% |
| Q3 2021 | $1,365,000 | -28.7% | 9,379 | -4.1% | 0.03% | -25.7% |
| Q2 2021 | $1,914,000 | +76.1% | 9,775 | +62.8% | 0.04% | +52.2% |
| Q1 2021 | $1,087,000 | +30.0% | 6,004 | +1.7% | 0.02% | +27.8% |
| Q4 2020 | $836,000 | +12.7% | 5,904 | -0.8% | 0.02% | 0.0% |
| Q3 2020 | $742,000 | +47.5% | 5,952 | +5.8% | 0.02% | +38.5% |
| Q2 2020 | $503,000 | – | 5,627 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |